Updates

Chemring - Take part profit

January 2007

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

In a pre-close update, Chemring has announced that trading has been strong and in line with expectations for the year ended 31 October. The countermeasures business continues to benefit from the high level of peacekeeping operations in Afghanistan and Iraq with major new orders coming from the US Army, Navy and Air Force. Trading on the smaller energetics business also showed good organic growth, with its newly acquired businesses performing well. Chemring’s overall order book now stands at £218m, which is 79% ahead of the same period last year. The shares have risen above £16 at times but have now entered a period of consolidation. Take a part profit. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Synergy Healthcare - Increases bid for Isotron

Spice

Chemring - Defence firm expects growth from “reverse peace dividend” (August 2022)

Chemring - Defence specialist winning big contracts with USâ€ˆmilitary (December 2019)

Chemring - Forward PE less than 6 but outlook increasingly uncertain (January 2012)

Chemring - Defence business finding new sources of growth (December 2011)

Chemring - Aquisitions driving share price higher (February 2010)

Chemring - Wins huge contract (November 2009)

Chemring - Defence firm exploiting activity in Iraq and Afghanistan (September 2009)

Chemring (November 2008)

Chemring - Eps of 193p forecast for 2009 (August 2008)

Chemring - Order book rises to a record £420m (May 2008)

Chemring - Defence firm set to increase eps 71% over next two years (March 2008)

Chemring - Order book up 50% (January 2008)

Chemring (June 2007)

Chemring - Shares break over Â£20 (May 2007)

Chemring - Eps forecasts raised 10% to 101p (March 2007)

Chemring - Order book hits another record (November 2006)

Chemring (August 2006)

Chemring (July 2006)

Chemring - Positive AGM (May 2006)

Chemring - Benefiting from massive US defence contract wins (April 2006)

Chemring - Supplier of countermeasures growing on back of US military spend (February 2006)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X